These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24092971)

  • 41. Desonide nanoencapsulation with açai oil as oil core: Physicochemical characterization, photostability study and in vitro phototoxicity evaluation.
    Rosa P; Friedrich ML; Dos Santos J; Librelotto DRN; Maurer LH; Emanuelli T; da Silva CB; Adams AIH
    J Photochem Photobiol B; 2019 Oct; 199():111606. PubMed ID: 31522112
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of matrix type mucoadhesive tablets containing indomethacin for buccal application.
    Ikeuchi-Takahashi Y; Sasatsu M; Onishi H
    Int J Pharm; 2013 Sep; 453(2):454-61. PubMed ID: 23791737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Controlled release of raloxifene by nanoencapsulation: effect on in vitro antiproliferative activity of human breast cancer cells.
    Fontana MC; Beckenkamp A; Buffon A; Beck RC
    Int J Nanomedicine; 2014; 9():2979-91. PubMed ID: 24971009
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
    Shah RM; Eldridge DS; Palombo EA; Harding IH
    Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Curcumin loaded pH-sensitive nanoparticles for the treatment of colon cancer.
    Prajakta D; Ratnesh J; Chandan K; Suresh S; Grace S; Meera V; Vandana P
    J Biomed Nanotechnol; 2009 Oct; 5(5):445-55. PubMed ID: 20201417
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of nanoaerosols of sparingly water-soluble drugs: the effect of indomethacin nanoparticles.
    Onishchuk AA; Tolstikova TG; Sorokina IV; Baklanov AM; Karasev VV; Boldyrev VV; Fomin VM
    Dokl Biochem Biophys; 2009; 425():106-9. PubMed ID: 19496334
    [No Abstract]   [Full Text] [Related]  

  • 47. Poly n-butylcyanoacrylate (PNBCA) nanocapsules as a carrier for NSAIDs: in vitro release and in vivo skin penetration.
    Miyazaki S; Takahashi A; Kubo W; Bachynsky J; Löebenberg R
    J Pharm Pharm Sci; 2003; 6(2):238-45. PubMed ID: 12935436
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physico-chemical characterization and in vivo evaluation of indomethacin ethyl ester-loaded nanocapsules by PCS, TEM, SAXS, interfacial alkaline hydrolysis and antiedematogenic activity.
    Cruz L; Schaffazick SR; Dalla Costa T; Soares LU; Mezzalira G; da Silveira NP; Schapoval EE; Pohlmann AR; Guterres SS
    J Nanosci Nanotechnol; 2006; 6(9-10):3154-62. PubMed ID: 17048531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. One-step production of darunavir solid dispersion nanoparticles coated with enteric polymers using electrospraying.
    Nguyen DN; Palangetic L; Clasen C; Van den Mooter G
    J Pharm Pharmacol; 2016 May; 68(5):625-33. PubMed ID: 26272245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility study into the potential use of fused-deposition modeling to manufacture 3D-printed enteric capsules in compounding pharmacies.
    Nober C; Manini G; Carlier E; Raquez JM; Benali S; Dubois P; Amighi K; Goole J
    Int J Pharm; 2019 Oct; 569():118581. PubMed ID: 31369828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of indomethacin-loaded nanocapsules incorporation in a dentin adhesive resin.
    Genari B; Leitune VC; Jornada DS; Camassola M; Pohlmann AR; Guterres SS; Samuel SM; Collares FM
    Clin Oral Investig; 2017 Jan; 21(1):437-446. PubMed ID: 27068412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a novel intraarticular injection of diclofenac for the treatment of arthritis: a preclinical study in the rabbit model.
    Wen X; Huang X; Wu H
    Acta Biochim Pol; 2021 Jan; 68(1):71-76. PubMed ID: 33480230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Indomethacin-loaded polymeric nanocarriers based on amphiphilic polyphosphazenes with poly (N-isopropylacrylamide) and ethyl tryptophan as side groups: Preparation, in vitro and in vivo evaluation.
    Zhang JX; Li XJ; Qiu LY; Li XH; Yan MQ; Yi Jin ; Zhu KJ
    J Control Release; 2006 Dec; 116(3):322-9. PubMed ID: 17109985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indomethacin electrospun nanofibers for colonic drug delivery: In vitro dissolution studies.
    Akhgari A; Heshmati Z; Afrasiabi Garekani H; Sadeghi F; Sabbagh A; Sharif Makhmalzadeh B; Nokhodchi A
    Colloids Surf B Biointerfaces; 2017 Apr; 152():29-35. PubMed ID: 28064095
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug release from xyloglucan beads coated with Eudragit for oral drug delivery.
    Yoo MK; Choi HK; Kim TH; Choi YJ; Akaike T; Shirakawa M; Cho CS
    Arch Pharm Res; 2005 Jun; 28(6):736-42. PubMed ID: 16042085
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.
    Chokshi RJ; Sandhu HK; Iyer RM; Shah NH; Malick AW; Zia H
    J Pharm Sci; 2005 Nov; 94(11):2463-74. PubMed ID: 16200544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissolution behaviour of sustained release formulations of indomethacin with Eudragit RS.
    Khanfar MS; Salem MS; Najib NM; Pillai GK
    Acta Pharm Hung; 1997 Nov; 67(6):235-9. PubMed ID: 9423295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elaboration and structural analysis of aquasomes loaded with indomethacin.
    Rojas-Oviedo I; Salazar-López RA; Reyes-Gasga J; Quirino-Barreda CT
    Eur J Pharm Sci; 2007 Nov; 32(3):223-30. PubMed ID: 17905573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formulation development of self-nanoemulsifying drug delivery system of celecoxib for the management of oral cavity inflammation.
    Salem HF; Kharshoum RM; Sayed OM; Abdel Hakim LF
    J Liposome Res; 2019 Jun; 29(2):195-205. PubMed ID: 30221598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.